Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 27, Number 11—November 2021
Research

Probability-Based Estimates of Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence and Detection Fraction, Utah, USA

Matthew H. SamoreComments to Author , Adam Looney, Brian Orleans, Tom Greene, Nathan Seegert, Julio C. Delgado, Angela Presson, Chong Zhang, Jian Ying, Yue Zhang, Jincheng Shen, Patricia Slev, Maclean Gaulin, Mu-Jeung Yang, Andrew T. Pavia, and Stephen C. Alder
Author affiliations: Veterans Affairs Salt Lake City Health Care System, Salt Lake City, Utah, USA (M.H. Samore); University of Utah, Salt Lake City (M.H. Samore, A. Looney, B. Orleans, T. Greene, N. Seegert, J.C. Delgago, A. Presson, C. Zhang, J. Ying, Y. Zhang, J. Shen, P. Slev, M. Gaulin, M.-J. Yang, A.T. Pavia, S.C. Alder)

Main Article

Table 4

Relationship between COVID-19 exposures and serologic results of participants in a study of SARS-CoV-2 seroprevalence, Utah, USA*

Exposures Total No. (%) seronegative, n = 8,019 No. (%) seropositive, n = 89 % Adjusted seroprevalence (95% CI)†
Contact with diagnosed COVID-19 case
 360
 334 (92.8)
 26 (7.2)
 8.5 (3.3–19.5)
Participant’s relationship with contact
Family member 97 83 (85.6) 14 (14.4) 14.8 (4.0–40.8)
Friend 42 38 (90.5) 4 (9.5) 14.0
Healthcare worker‡ 38 38 (100) 0 (0) 0.0
Coworker 105 102 (97.1) 3 (2.9) 3.4
Other
 78
 73 (93.6)
 5 (6.4)
 3.1 (0.3–12.9)
Reside in household with >1 seropositive person 123 100 (81.3) 23 (18.7) 24.9 (10.5–48.7)

*COVID-19, coronavirus disease; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2. †Adjusted for sampling design and test sensitivity (0.83) and specificity (0.996). Confidence intervals are omitted for subgroups with fewer than 5 seropositive persons. ‡Participant reported that their exposure was related to their work as a healthcare worker.

Main Article

Page created: August 05, 2021
Page updated: October 19, 2021
Page reviewed: October 19, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external